1. Multi-chamber cardioids unravel human heart development and cardiac defects
   Clara Schmidt et al, 2023, Cell CrossRef
2. Anti-emetic effects of thalidomide: Evidence, mechanism of action, and future directions
   Paul L.R. Andrews et al, 2022, Current Research in Pharmacology and Drug Discovery CrossRef
3. Animal-free assessment of developmental toxicity: Combining PBPK modeling with the ReproTracker assay
   Marjory Moreau et al, 2023, Toxicology CrossRef
4. LC–MS/MS method for simultaneous determination of thalidomide, lenalidomide, cyclophosphamide, bortezomib, dexamethasone and adriamycin in serum of multiple myeloma patients
   Chang Shu et al, 2016, Journal of Chromatography B CrossRef
5. Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome
   Katherine A Donovan et al, 2018, eLife CrossRef
6. Thalidomide Measurement in Plasma and Dried Plasma Spot by SPE Combined with UHPLC-MS/MS for Therapeutic Drug Monitoring
   Renata Soares Novellino et al, 2022, Bioanalysis CrossRef
7. Selective Sensing of Darolutamide and Thalidomide in Pharmaceutical Preparations and in Spiked Biofluids
   Wael Talaat et al, 2022, Biosensors CrossRef
8. Thalidomide remodels developing heart in chick embryo: discovery of a thalidomide mediated hematoma in heart muscle
   Pavitra Kumar et al, 2018, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
9. Old wine in new bottles: Drug repurposing in oncology
   Michał Antoszczak et al, 2020, European Journal of Pharmacology CrossRef
10. A validated LC–MS/MS method for the simultaneous determination of thalidomide and its two metabolites in human plasma: Application to a pharmacokinetic assay
    Fulin Jiang et al, 2018, Biomedical Chromatography CrossRef
11. Improved approach for comprehensive profiling of gangliosides and sulfatides in rat brain tissues by using UHPLC-Q-TOF-MS
    Xiong-Yu Meng et al, 2019, Chemistry and Physics of Lipids CrossRef